Richard T. Miller, RPh, MBA

As part of its pharmacist-driven ConnectedCare Oral Oncology Program, Walgreens Specialty Pharmacy recently conducted a unique 3-month monitored-dispense pilot program, which reflects continued innovation, additional cost savings, and improved health care system communication.

The challenges of new oral chemotherapy treatments lead to a renewed focus on high-touch patient care and the expanded role of the specialty pharmacist.